Flamel Technologies SA (FLML.OQ)

FLML.OQ on NASDAQ Stock Exchange Global Market

19 Dec 2014
Price Change (% chg)

$2.44 (+14.83%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for FLML.OQ


Flamel Technologies SA has a pipeline of niche specialty pharmaceutical products. The Company’s drug delivery platforms are focused on developing safer, more efficacious formulations of drugs to address unmet medical needs. Its pipeline includes biological and chemical drugs formulated with its Medusa and Micropump (and its... (more)


Beta: 0.78
Market Cap (Mil.): $729.41
Shares Outstanding (Mil.): 38.61
Dividend: --
Yield (%): --


  FLML.OQ Industry Sector
P/E (TTM): -- 179.07 38.47
EPS (TTM): -1.55 -- --
ROI: -- -0.72 18.25
ROE: -- -1.88 19.13
Search Stocks

BRIEF-Recipharm to buy Flamel Technologies facility in France

* Recipharm acquires flamel technologies facility and extend development services in France

27 Nov 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: GlobalData
Provider: MacroRisk Analytics/EconomicInvestor
Provider: ValuEngine, Inc.
Provider: S&P Capital IQ Quantitative Report

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks